KIT and fatty liver disease: Another study reported that c-Kit mice with a chemical-induced hypomorphic point mutation displayed increased juvenile hepatic steatosis, suggesting that c-Kit also can control aspects of lipid metabolism in the liver (Magnol et al., 2007).